Two types of gamma T cell receptors expressed by T cell acute lymphoblastic leukemias. 1987

J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
Department of Cell Biology, Immunology and Genetics, Erasmus University, Rotterdam, The Netherlands.

CD3+ cells, isolated from peripheral blood of two patients with T cell acute lymphoblastic leukemia (T-ALL), did not react with the monoclonal antibody WT31, which is thought to recognize a framework determinant on the conventional T cell receptor (TcR), consisting of disulfide-linked alpha and beta chains. The T-ALL cells of neither patient synthesized TcR alpha mRNA; the cells of patient DD contained only truncated (D-J) TcR beta mRNA, while the cells of patient HZ contained truncated as well as mature (V-D-J) TcR beta mRNA. The leukemic cells of both patients made TcR gamma mRNA. At the cell surface, the T-ALL cells of patient DD expressed a CD3-associated disulfide-linked dimer, which contained the TcR gamma protein. On the leukemic cells of patient HZ the TcR gamma protein was present as a 41-44-kDa CD3-associated subunit in a noncovalently linked form. The TcR gamma genes in the T-ALL cells of patient DD were rearranged exclusively to the C gamma 1 locus, while in the T-ALL cells of patient HZ both C gamma 1 alleles were deleted and rearrangement to the C gamma 2 locus had occurred. The C gamma 1 gene segment, just like the TcR alpha and TcR beta gene segments, contains a cysteine codon in its second exon. This cysteine residue is involved in the formation of the interchain disulfide bond. The human C gamma 2 gene segment, however, does not contain a cysteine codon in its second exon. The absence of the cysteine residue in C gamma 2 encoded TcR gamma chains explains the lack of an interchain disulfide bond in the TcR on the T-ALL cells of patient HZ. The TcR gene configuration, as well as the expression of model for T cell differentiation in which the TcR gamma gene rearranges first to the C gamma 1 locus prior to or coinciding with D-J joining of the TcR beta gene, followed by rearrangement to the C gamma 2 locus and V-D-J joining of the TcR beta gene.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
January 1990, Nouvelle revue francaise d'hematologie,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
April 2007, American journal of clinical pathology,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
January 1990, Cancer genetics and cytogenetics,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
January 1982, Acta haematologica,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
November 1987, European journal of immunology,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
January 1997, Haematologica,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
May 1977, Clinical immunology and immunopathology,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
December 2014, Blood,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
January 2004, Genomics,
J J Van Dongen, and I L Wolvers-Tettero, and J G Seidman, and S L Ang, and R J Van de Griend, and E F De Vries, and J Borst
July 2004, Blood,
Copied contents to your clipboard!